195 related articles for article (PubMed ID: 12884834)
1. Back from the Peace Corps--with skin lesions from South America.
Sorci JJ; Cordova X; Usatine RP
J Fam Pract; 2003 Jul; 52(7):531-6. PubMed ID: 12884834
[No Abstract] [Full Text] [Related]
2. A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
Krolewiecki AJ; Romero HD; Cajal SP; Abraham D; Mimori T; Matsumoto T; Juarez M; Taranto NJ
Am J Trop Med Hyg; 2007 Oct; 77(4):640-6. PubMed ID: 17978064
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cutaneous leishmaniasis in travelers 2009.
Blum JA; Hatz CF
J Travel Med; 2009; 16(2):123-31. PubMed ID: 19335813
[No Abstract] [Full Text] [Related]
4. Symmetrical cutaneous leishmaniasis.
Guarneri C; Guarneri F
Acta Derm Venereol; 2005; 85(3):281-2. PubMed ID: 16040429
[No Abstract] [Full Text] [Related]
5. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.
Soto J; Rea J; Balderrama M; Toledo J; Soto P; Valda L; Berman JD
Am J Trop Med Hyg; 2008 Feb; 78(2):210-1. PubMed ID: 18256415
[TBL] [Abstract][Full Text] [Related]
6. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
Andersen EM; Cruz-Saldarriaga M; Llanos-Cuentas A; Luz-Cjuno M; Echevarria J; Miranda-Verastegui C; Colina O; Berman JD
Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547
[TBL] [Abstract][Full Text] [Related]
7. American tegumentary leishmaniasis in older adults: 44 cases treated with an intermittent low-dose antimonial schedule in Rio de Janeiro, Brazil.
de Camargo Ferreira E Vasconcellos E; de Oliveira Schubach A; Valete-Rosalino CM; de Souza Coutinho R; Conceição-Silva F; de Matos Salgueiro M; Rosandiski Lyra M; Soares Moreira J; Azeredo-Coutinho RB; Fernandes Pimentel MI; Roberto Mortari S; de Fátima Madeira M; Pereira Quintella L; Baptista C; de Almeida Marzochi MC
J Am Geriatr Soc; 2010 Mar; 58(3):614-6. PubMed ID: 20398135
[No Abstract] [Full Text] [Related]
8. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
Moosavi Z; Nakhli A; Rassaii S
Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
[No Abstract] [Full Text] [Related]
9. Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate.
Shamsi Meymandi S; Zandi S; Aghaie H; Heshmatkhah A
J Eur Acad Dermatol Venereol; 2011 May; 25(5):587-91. PubMed ID: 20666876
[TBL] [Abstract][Full Text] [Related]
10. Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens.
Oliveira-Neto MP; Schubach A; Mattos M; Gonçalves-Costa SC; Pirmez C
Pathol Biol (Paris); 1997 Jun; 45(6):496-9. PubMed ID: 9309267
[TBL] [Abstract][Full Text] [Related]
11. [Glucantime reaction with fatal outcome following treatment of cutaneous leishmaniasis].
Hajlaoui K; Zeglaoui F; Ezzine N; Kastalli S; Elfekih N; Fazaa B; Loueslati MH; Kamoun MR
Ann Dermatol Venereol; 2008 Apr; 135(4):317-8. PubMed ID: 18420083
[No Abstract] [Full Text] [Related]
12. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
[TBL] [Abstract][Full Text] [Related]
13. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
Teva A; Porrozzi R; Oliveira-Neto MP; Grimaldi GJ
J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
[TBL] [Abstract][Full Text] [Related]
14. Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey.
Uzun S; Durdu M; Culha G; Allahverdiyev AM; Memisoglu HR
J Parasitol; 2004 Aug; 90(4):853-9. PubMed ID: 15357081
[TBL] [Abstract][Full Text] [Related]
15. Antimony in plasma and skin of patients with cutaneous leishmaniasis--relationship with side effects after treatment with meglumine antimoniate.
Neves DB; Caldas ED; Sampaio RN
Trop Med Int Health; 2009 Dec; 14(12):1515-22. PubMed ID: 19954451
[TBL] [Abstract][Full Text] [Related]
16. [Sporotrichoid cutaneous leishmaniasis].
López-Escobar M; Drake-Monfort M; Salesa-Gutiérrez de Rozas R; Hermana-Ramírez S
Actas Dermosifiliogr; 2007; 98(6):444-5. PubMed ID: 17663940
[No Abstract] [Full Text] [Related]
17. Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis.
de Morais-Teixeira E; Aguiar MG; Soares de Souza Lima B; Ferreira LA; Rabello A
J Antimicrob Chemother; 2015 Dec; 70(12):3283-90. PubMed ID: 26346991
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.
Salmanpour R; Handjani F; Nouhpisheh MK
J Dermatolog Treat; 2001 Sep; 12(3):159-62. PubMed ID: 12243707
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
Layegh P; Yazdanpanah MJ; Vosugh EM; Pezeshkpoor F; Shakeri MT; Moghiman T
Am J Trop Med Hyg; 2007 Jul; 77(1):99-101. PubMed ID: 17620637
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous leishmaniasis with pseudoepitheliomatous hyperplasia simulating squamous cell carcinoma.
Quintella LP; Cuzzi T; de Fátima Madeira M; Valete-Rosalino CM; de Matos Salgueiro M; de Camargo Ferreira e Vasconcellos E; Mouta-Confort E; Lambert Passos SR; de Oliveira Schubach A
Am J Dermatopathol; 2011 Aug; 33(6):642-4. PubMed ID: 21778837
[No Abstract] [Full Text] [Related]
[Next] [New Search]